• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哺乳动物硫酸酯酶:生物化学、疾病表现及治疗。

Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy.

机构信息

Department of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.

TOKIWA-Bio Inc., 2-1-6 Sengen, Tsukuba 305-0047, Japan.

出版信息

Int J Mol Sci. 2022 Jul 24;23(15):8153. doi: 10.3390/ijms23158153.

DOI:10.3390/ijms23158153
PMID:35897729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330403/
Abstract

Sulfatases are enzymes that catalyze the removal of sulfate from biological substances, an essential process for the homeostasis of the body. They are commonly activated by the unusual amino acid formylglycine, which is formed from cysteine at the catalytic center, mediated by a formylglycine-generating enzyme as a post-translational modification. Sulfatases are expressed in various cellular compartments such as the lysosome, the endoplasmic reticulum, and the Golgi apparatus. The substrates of mammalian sulfatases are sulfolipids, glycosaminoglycans, and steroid hormones. These enzymes maintain neuronal function in both the central and the peripheral nervous system, chondrogenesis and cartilage in the connective tissue, detoxification from xenobiotics and pharmacological compounds in the liver, steroid hormone inactivation in the placenta, and the proper regulation of skin humidification. Human sulfatases comprise 17 genes, 10 of which are involved in congenital disorders, including lysosomal storage disorders, while the function of the remaining seven is still unclear. As for the genes responsible for pathogenesis, therapeutic strategies have been developed. Enzyme replacement therapy with recombinant enzyme agents and gene therapy with therapeutic transgenes delivered by viral vectors are administered to patients. In this review, the biochemical substrates, disease manifestation, and therapy for sulfatases are summarized.

摘要

硫酸酯酶是一类能够催化生物体内硫酸盐基团去除的酶,对于维持体内平衡至关重要。它们通常被一种特殊的氨基酸甲酰甘氨酸激活,这种氨基酸由甲酰甘氨酸生成酶在翻译后修饰过程中从半胱氨酸形成。硫酸酯酶在各种细胞区室中表达,如溶酶体、内质网和高尔基体。哺乳动物硫酸酯酶的底物是硫脂、糖胺聚糖和类固醇激素。这些酶在中枢和周围神经系统中维持神经元功能,在结缔组织中维持软骨形成和软骨,在肝脏中解毒外来物质和药理学化合物,在胎盘中介导类固醇激素失活,并适当调节皮肤保湿。人类硫酸酯酶由 17 个基因组成,其中 10 个与先天性疾病有关,包括溶酶体贮积症,而其余 7 个的功能仍不清楚。至于导致发病的基因,已经开发出了治疗策略。通过重组酶制剂的酶替代疗法和通过病毒载体传递的治疗性转基因的基因疗法已用于患者治疗。在这篇综述中,总结了硫酸酯酶的生化底物、疾病表现和治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348e/9330403/c10a1dc66fca/ijms-23-08153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348e/9330403/c10a1dc66fca/ijms-23-08153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348e/9330403/c10a1dc66fca/ijms-23-08153-g001.jpg

相似文献

1
Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy.哺乳动物硫酸酯酶:生物化学、疾病表现及治疗。
Int J Mol Sci. 2022 Jul 24;23(15):8153. doi: 10.3390/ijms23158153.
2
Lysosomal sulfatases: a growing family.溶酶体硫酸酯酶:一个不断壮大的家族。
Biochem J. 2020 Oct 30;477(20):3963-3983. doi: 10.1042/BCJ20200586.
3
A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease.一种在硫酸酯酶中产生醛基的新型蛋白质修饰:其在催化作用和疾病中的作用。
Bioessays. 1998 Jun;20(6):505-10. doi: 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K.
4
SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies.SUMF1在体内增强了五种硫酸酯酶缺乏症中的硫酸酯酶活性。
Biochem J. 2007 Apr 15;403(2):305-12. doi: 10.1042/BJ20061783.
5
Sulfatase activities towards the regulation of cell metabolism and signaling in mammals.硫酸酯酶活性在哺乳动物细胞代谢和信号转导中的调节作用。
Cell Mol Life Sci. 2010 Mar;67(5):769-80. doi: 10.1007/s00018-009-0203-3. Epub 2009 Nov 22.
6
Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins.多种硫酸酯酶缺乏症、黏脂贮积症II/III型和尼曼-皮克C1病的分子基础——由非溶酶体蛋白缺陷引起的溶酶体贮积病。
Biochim Biophys Acta. 2009 Apr;1793(4):710-25. doi: 10.1016/j.bbamcr.2008.11.015. Epub 2008 Dec 10.
7
Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.多种硫酸酯酶缺乏症:一种由翻译后修饰缺陷引起的包含黏多糖贮积症、鞘脂贮积症等疾病的综合征。
Int J Mol Sci. 2020 May 13;21(10):3448. doi: 10.3390/ijms21103448.
8
Biochemical signatures of disease severity in multiple sulfatase deficiency.多种硫酸酯酶缺乏症中疾病严重程度的生化特征。
J Inherit Metab Dis. 2024 Mar;47(2):374-386. doi: 10.1002/jimd.12688. Epub 2023 Nov 1.
9
Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship.硫酸酯酶和硫酸酯酶修饰因子:一种独特而混杂的关系。
Hum Mol Genet. 2005 Nov 1;14(21):3203-17. doi: 10.1093/hmg/ddi351. Epub 2005 Sep 20.
10
Human sulfatases: a structural perspective to catalysis.人类硫酸酯酶:催化作用的结构视角
Cell Mol Life Sci. 2007 Aug;64(15):2013-22. doi: 10.1007/s00018-007-7175-y.

引用本文的文献

1
Arylsulfatase K attenuates airway epithelial cell senescence in COPD by regulating parkin-mediated mitophagy.芳基硫酸酯酶K通过调节帕金蛋白介导的线粒体自噬减轻慢性阻塞性肺疾病中的气道上皮细胞衰老。
Redox Biol. 2025 Jul 31;86:103793. doi: 10.1016/j.redox.2025.103793.
2
Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives.甾体酶抑制剂作为抗癌药物的发现与开发:现状与未来展望。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2483818. doi: 10.1080/14756366.2025.2483818. Epub 2025 Apr 2.
3
Steroid sulfatase and sulfotransferases in the estrogen and androgen action of gynecological cancers: current status and perspectives.

本文引用的文献

1
Long-term open-label phase I/II extension study of intrathecal idursulfase-IT in the treatment of neuronopathic mucopolysaccharidosis II.鞘内注射伊度硫酸酶-IT 治疗神经病变型黏多糖贮积症 II 型的长期开放性 I/II 期扩展研究。
Genet Med. 2022 Jul;24(7):1437-1448. doi: 10.1016/j.gim.2022.04.002. Epub 2022 May 20.
2
Exciting Times for Lipid Nanoparticles: How Canadian Discoveries Are Enabling Gene Therapies.脂质纳米颗粒的激动人心时刻:加拿大的发现如何使基因疗法成为可能。
Mol Pharm. 2022 Jun 6;19(6):1663-1668. doi: 10.1021/acs.molpharmaceut.2c00365. Epub 2022 May 18.
3
Sulfatases: Critical Enzymes for Algal Polysaccharide Processing.
甾体硫酸酯酶和硫酸转移酶在妇科癌症雌激素和雄激素作用中的研究现状与展望
Essays Biochem. 2024 Dec 4;68(4):411-422. doi: 10.1042/EBC20230096.
4
New Insights into the Detoxifying Enzymes: Sequence Evolution, Structural Similarity, Functional Diversity, and Application Prospects of Glucosinolate Sulfatases.解毒酶的新见解:硫代葡萄糖苷硫基水解酶的序列进化、结构相似性、功能多样性及应用前景。
J Agric Food Chem. 2023 Jul 26;71(29):10952-10969. doi: 10.1021/acs.jafc.3c03246. Epub 2023 Jul 18.
5
Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.用于残基特异性肽和蛋白质后期功能化的混杂酶。
Chembiochem. 2023 Sep 1;24(17):e202300372. doi: 10.1002/cbic.202300372. Epub 2023 Jul 19.
6
Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application.脂质纳米颗粒:一种用于临床应用的新型基因递送技术。
Curr Issues Mol Biol. 2022 Oct 19;44(10):5013-5027. doi: 10.3390/cimb44100341.
硫酸酯酶:藻类多糖加工的关键酶
Front Plant Sci. 2022 Apr 28;13:837636. doi: 10.3389/fpls.2022.837636. eCollection 2022.
4
Sulfation Pathways During Neurodevelopment.神经发育过程中的硫酸化途径。
Front Mol Biosci. 2022 Apr 14;9:866196. doi: 10.3389/fmolb.2022.866196. eCollection 2022.
5
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.慢病毒造血干细胞基因治疗早发性异染性脑白质营养不良:1/2 期非随机、开放标签、单臂临床试验及扩大使用的长期结果。
Lancet. 2022 Jan 22;399(10322):372-383. doi: 10.1016/S0140-6736(21)02017-1.
6
Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.定制血脑屏障穿梭肽以增加 AAV9 载体穿过血脑屏障并增强大脑中的转导。
Biomaterials. 2022 Feb;281:121340. doi: 10.1016/j.biomaterials.2021.121340. Epub 2021 Dec 31.
7
CAR T cells produced in vivo to treat cardiac injury.体内生成的 CAR T 细胞治疗心脏损伤。
Science. 2022 Jan 7;375(6576):91-96. doi: 10.1126/science.abm0594. Epub 2022 Jan 6.
8
Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases.用于治疗溶酶体贮积症的慢病毒载体设计中的启动子考量
Mol Ther Methods Clin Dev. 2021 Nov 24;24:71-87. doi: 10.1016/j.omtm.2021.11.007. eCollection 2022 Mar 10.
9
A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy.一种针对脑苷脂沉积病的突变不可知造血干细胞基因治疗方法。
CRISPR J. 2022 Feb;5(1):66-79. doi: 10.1089/crispr.2021.0075. Epub 2021 Dec 8.
10
Steroid sulfatase deficiency causes cellular senescence and abnormal differentiation by inducing Yippee-like 3 expression in human keratinocytes.类固醇硫酸酯酶缺乏通过诱导人角质形成细胞中 Yippee 样 3 的表达引起细胞衰老和异常分化。
Sci Rep. 2021 Oct 21;11(1):20867. doi: 10.1038/s41598-021-00051-w.